Jefferies Initiates La Jolla Pharma With Buy

Analysts at Jefferies initiated coverage on La Jolla Pharma

with a Buy rating. The target price for La Jolla Pharma is set to $25. La Jolla Pharma shares have surged 168.57% over the past 52 weeks, while the S&P 500 index has gained 12.60% in the same period. La Jolla Pharma's shares dropped 3.53% to close at $9.40 on Friday.